The prevalence of acromegaly is higher than previously reported: Changes over a three-decade period.

Charlotte AagaardAmanda S ChristophersenSusanne FinnerupChristian A H RosendalHelga A GulisanoKåre S EttrupPeter VestergaardJesper KarmisholtEigil Husted NielsenJakob Dal

Published in: Clinical endocrinology (2022)

The prevalence of acromegaly is higher than previously reported and the clinical presentation has shifted towards a milder phenotype. Modern treatment of acromegaly enables individualized treatment and disease control in the majority of patients.

Keyphrases

end stage renal disease
risk factors
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
growth hormone
combination therapy
patient reported outcomes
replacement therapy
patient reported